Post-Marketing Surveillance of TISSUCOL for Hemostasis in Subjects Undergoing Vascular Reconstruction With Polytetrafluoroethylene (PTFE) Prosthesis

Baxter

Status: Completed

Conditions: Femoral Vascular Anastomosis

Treatments: Drug: Tissucol®; Procedure: Control: Conventional treatment, i.e. compression with swabs

Study type: Observational

Funder types: Industry

Identifiers

NCT00163592

530301

Details and patient eligibility

About

This study investigates if the time to hemostasis can be reduced by application of Tissucol® onto femoral vascular anastomoses with PTFE prostheses compared to standard methods, such as compression with swabs.

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Subjects with femoral vascular anastomosis and bleeding suture holes after vessel reconstruction with a PTFE prosthesis